Innovation
12 patent families (3 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace steady. Cited 294 times.
| Year | Filings |
|---|---|
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 3 |
| 2022 | 5 |
| 2023 | 4 |
| 2024 | 5 |
| 2025 | 6 |
| 2026 | 4 |
Social engagement
Social engagement: 1.8K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
1 investor on record.
| Investor type | Count | Share |
|---|---|---|
| Other / undisclosed | 1 | 100% |
Recent activity
2 Jul 2026
Leadership hire
Spinogenix Scientific Advisory Board member
16 Jun 2026
Product launch
tazbentetol
4 Jun 2026
Event
FRAXA Research Foundation webinar on Fragile X Treatment pipeline